Intrathecal Morphine + Clonidine for Lumbar Fusion Surgery

This trial explores two methods of pain control for individuals undergoing spinal fusion surgery. Participants will receive either the standard pain treatment with intrathecal morphine (a pain medication delivered into the spinal fluid) or an experimental combination of intrathecal morphine and clonidine, a drug that might enhance pain relief. The researchers aim to determine if adding clonidine can improve pain control after surgery. Eligible participants must speak English, be scheduled for lumbar spine fusion surgery, and plan to stay in the hospital for at least 24 hours post-procedure. While joining the trial might not directly benefit participants, it could lead to improved pain management options for future patients. As a Phase 3 trial, this study represents the final step before FDA approval, offering a chance to contribute to a potentially groundbreaking pain management solution.

Research has shown that combining intrathecal morphine and clonidine can help manage pain after spine surgeries. In one study, patients who received clonidine with morphine reported good pain relief. However, this combination can cause side effects, such as dose-dependent slowed breathing.

Patients using intrathecal morphine have experienced effective pain relief but may also face side effects like nausea and itching. Adding clonidine to morphine has reduced the need for extra pain medication, suggesting its effectiveness.

Unlike the standard treatment for pain management in lumbar fusion surgery, which typically involves intrathecal morphine alone, this new approach combines intrathecal morphine with intrathecal clonidine. Researchers are excited about this combination because clonidine is known to enhance pain relief by acting on different receptors in the spinal cord, potentially leading to better pain control with fewer side effects. This dual-action method could mean more effective pain management and a smoother recovery process for patients undergoing lumbar fusion surgery.

Research has shown that combining intrathecal morphine with clonidine can better manage pain for patients undergoing lumbar fusion surgery. In this trial, some participants will receive intrathecal morphine alone, the current standard of care, while others will receive the experimental treatment, which adds intrathecal clonidine to the standard morphine regimen. Studies have found that clonidine, when used with morphine, can enhance pain relief and may allow for lower morphine doses. This combination might also reduce the risk of side effects often associated with higher morphine doses. Clonidine works by affecting specific parts of the nervous system that control pain. Early results suggest this method can provide better pain management than morphine alone.